Astellas Pharma
Dedicated to the development of high-quality peer-reviewed publications covering Astellas products that are compliant with applicable regulations and guidance.
Enterprise value
$20.3b
Share price
€8.10 YPH.F
Recent deals
Corporate Venture Fund
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
N/A | Grant | ||
| Total Funding | 000k | ||
| JPY | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 4 % | 17 % | 6 % | 19 % | 2 % | 4 % | (7 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 17 % | 16 % | 12 % | 13 % | 22 % | 25 % | 26 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 10 % | 7 % | 1 % | 3 % | 7 % | 10 % | 10 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 19 % | 18 % | 18 % | 17 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Astellas Pharma
Edit
ACQUISITION by Astellas Pharma Oct 2016
ACQUISITION by Astellas Pharma Apr 2023
ACQUISITION by Astellas Pharma Apr 2020
ACQUISITION by Astellas Pharma Dec 2019
ACQUISITION by Astellas Pharma Dec 2007
exited
ACQUISITION by Astellas Pharma Apr 2017
ACQUISITION by Astellas Pharma Feb 2018